{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:47:51Z","timestamp":1787510871603,"version":"build-2736575974"},"reference-count":56,"publisher":"Impact Journals, LLC","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,6,27]]},"DOI":"10.18632\/oncotarget.17198","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T15:28:07Z","timestamp":1492529287000},"page":"42466-42477","source":"Crossref","is-referenced-by-count":12,"title":["Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma"],"prefix":"10.18632","volume":"8","author":[{"given":"Toshiyuki","family":"Satoh","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacotherapeutics, Tohoku Medical and Pharmaceutical University, Aobaku, Sendai, Miyagi 981-8558, Japan"},{"name":"Division of Cell Recognition Study, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Aobaku, Sendai, Miyagi 981-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Tatsuta","sequence":"additional","affiliation":[{"name":"Division of Cell Recognition Study, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Aobaku, Sendai, Miyagi 981-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Division of Cell Recognition Study, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Aobaku, Sendai, Miyagi 981-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacotherapeutics, Tohoku Medical and Pharmaceutical University, Aobaku, Sendai, Miyagi 981-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hosono","sequence":"additional","affiliation":[{"name":"Division of Cell Recognition Study, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Aobaku, Sendai, Miyagi 981-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Kindler","year":"2009","journal-title":"J Clin Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Lake","year":"2005","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bmj.2.5403.214","article-title":"Diffuse Mesothelioma and Exposure to Asbestos Dust in the Merseyside Area","volume":"2","author":"Owen","year":"1964","journal-title":"Br Med J"},{"key":"4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/1547691X.2016.1143539","article-title":"FoxO1 regulates apoptosis induced by asbestos in the MT-2 human T-cell line","volume":"13","author":"Otsuki","year":"2016","journal-title":"J Immunotoxicol"},{"key":"5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/oemed-2016-103652","article-title":"Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections","volume":"73","author":"Consonni","year":"2016","journal-title":"Occup Environ Med"},{"issue":"Suppl 2","key":"6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1289\/ehp.99107s2289","article-title":"Asbestos and cancer: An overview of current trends in Europe","volume":"107","author":"Shefer","year":"1999","journal-title":"Environ Health Perspect"},{"key":"7","first-page":"718","article-title":"Latent period for malignant mesothelioma of occupational origin","volume":"34","author":"Buncher","year":"1992","journal-title":"J Occup Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1002\/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L","article-title":"Latency of asbestos disease among insulation workers in the United States and Canada","volume":"46","author":"Seidman","year":"1980","journal-title":"Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.lungcan.2004.04.008","article-title":"The epidemiology of asbestos-related diseases","volume":"45","author":"Pluygers","year":"2004","journal-title":"Lung Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Paoletti","year":"2003","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.hoc.2005.09.010","article-title":"An overview of chemotherapy for mesothelioma","volume":"19","author":"Krug","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"12","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2174\/1389450116666141205160924","article-title":"Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells","volume":"15","author":"Giovannetti","year":"2014","journal-title":"Curr Drug Targets"},{"key":"13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/1078-0432.982.11.3","article-title":"Pemetrexed in malignant pleural mesothelioma","volume":"11","author":"Garvey","year":"2005","journal-title":"Clin Cancer Res"},{"key":"14","first-page":"33","article-title":"Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines","volume":"28","author":"Tatsumi","year":"2012","journal-title":"Oncol Rep"},{"key":"15","first-page":"4877","article-title":"Isolation and characterization of Rana catesbeiana lectin and demonstration of the lectin-binding glycoprotein of rodent and human tumor cell membranes","volume":"47","author":"Hakomori","year":"1987","journal-title":"Cancer Res"},{"key":"16","first-page":"920","article-title":"Inhibition of cell proliferation by Rana catesbeiana and Rana japonica lectins belonging to the ribonuclease superfamily","volume":"54","author":"Hakomori","year":"1994","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/glycob\/3.1.37","article-title":"Ribonuclease activity of sialic acid-binding lectin from Rana catesbeiana eggs","volume":"3","author":"Titani","year":"1993","journal-title":"Glycobiology"},{"key":"18","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3892\/ijo.2013.2128","article-title":"Involvement of ER stress in apoptosis induced by sialic acid-binding lectin (leczyme) from bullfrog eggs","volume":"43","author":"Nitta","year":"2013","journal-title":"Int J Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3892\/ijo.2013.2092","article-title":"Sialic acid-binding lectin (leczyme) induces caspase-dependent apoptosis-mediated mitochondrial perturbation in Jurkat cells","volume":"43","author":"Nitta","year":"2013","journal-title":"Int J Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10719-013-9513-7","article-title":"Sialyl-glycoconjugates in cholesterol-rich microdomains of P388 cells are the triggers for apoptosis induced by Rana catesbeiana oocyte ribonuclease","volume":"31","author":"Yasumitsu","year":"2014","journal-title":"Glycoconj J"},{"key":"21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.febslet.2004.11.086","article-title":"Synergism of Rana catesbeiana ribonuclease and IFN-gamma triggers distinct death machineries in different human cancer cells","volume":"579","author":"Wang","year":"2005","journal-title":"FEBS Lett"},{"key":"22","first-page":"849","article-title":"RC-RNase-induced cell death in estrogen receptor positive breast tumors through down-regulation of Bcl-2 and estrogen receptor","volume":"25","author":"Yiang","year":"2011","journal-title":"Oncol Rep"},{"key":"23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-5793(01)02691-6","article-title":"Caspase activation in response to cytotoxic Rana catesbeiana ribonuclease in MCF-7 cells","volume":"503","author":"Wang","year":"2001","journal-title":"FEBS Lett"},{"key":"24","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3892\/ijo.2016.3656","article-title":"RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3\/7 signaling pathway in human breast cancer cells","volume":"49","author":"Hosono","year":"2016","journal-title":"Int J Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3892\/ijo.2013.2192","article-title":"Sialic acid-binding lectin (leczyme) induces apoptosis to malignant mesothelioma and exerts synergistic antitumor effects with TRAIL","volume":"44","author":"Nitta","year":"2014","journal-title":"Int J Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/prep.1996.0027","article-title":"Large-scale preparation of a ribonuclease from Rana catesbeiana (bullfrog) oocytes and characterization of its specific cytotoxic activity against tumor cells","volume":"7","author":"Kuo","year":"1996","journal-title":"Protein Expr Purif"},{"key":"27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1006\/bbrc.2001.4272","article-title":"Synergistic cytotoxicity of Rana catesbeiana ribonuclease and IFN-gamma on hepatoma cells","volume":"280","author":"Wang","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.antiviral.2011.01.002","article-title":"Rana catesbeiana ribonuclease inhibits Japanese encephalitis virus (JEV) replication and enhances apoptosis of JEV-infected BHK-21 cells","volume":"89","author":"Chiou","year":"2011","journal-title":"Antiviral Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"18309","DOI":"10.18632\/oncotarget.7579","article-title":"A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells","volume":"7","author":"Vilanova","year":"2016","journal-title":"Oncotarget"},{"key":"30","first-page":"1253","article-title":"Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells","volume":"33","author":"Liu","year":"2013","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"31","doi-asserted-by":"crossref","first-page":"e97888","DOI":"10.1371\/journal.pone.0097888","article-title":"Pemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.7314\/APJCP.2015.16.4.1507","article-title":"Pemetrexed induces G1 phase arrest and apoptosis through inhibiting Akt activation in human non small lung cancer cell line A549","volume":"16","author":"Wang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-4598-11-25","article-title":"Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells","volume":"11","author":"L\u00f3pez-Vivanco","year":"2012","journal-title":"Mol Cancer"},{"key":"34","doi-asserted-by":"crossref","first-page":"e0149120","DOI":"10.1371\/journal.pone.0149120","article-title":"Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating alpha5-nAChR\/AKT Signaling in Human Gastric Cancer Cells","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","article-title":"Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma","volume":"15","author":"Willems","year":"2009","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4161\/cbt.27623","article-title":"Abrogating G2\/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma","volume":"15","author":"Giordano","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jjco\/hyv039","article-title":"A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index","volume":"45","author":"Fukuhara","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.18632\/oncotarget.2186","article-title":"CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome","volume":"5","author":"Funaro","year":"2014","journal-title":"Oncotarget"},{"key":"39","first-page":"1","article-title":"Leczyme: A New Candidate Drug for Cancer Therapy","volume":"2014","author":"Nitta","year":"2014","journal-title":"Biomed Res Int"},{"key":"40","first-page":"139","article-title":"Cancer-selective induction of apoptosis by leczyme","volume":"4","author":"Nitta","year":"2014","journal-title":"Front Oncol"},{"key":"41","first-page":"928","article-title":"Characterization of a Rana catesbeiana lectin-resistant mutant of leukemia P388 cells","volume":"54","author":"Sasaki","year":"1994","journal-title":"Cancer Res"},{"key":"42","first-page":"3761","article-title":"A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents","volume":"59","author":"Roninson","year":"1999","journal-title":"Cancer Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/ijc.23896","article-title":"OSU03012 activates Erk1\/2 and Cdks leading to the accumulation of cells in the S-phase and apoptosis","volume":"123","author":"D\u2019Ambrosio","year":"2008","journal-title":"Int J Cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.RES.88.4.408","article-title":"Cyclin A\/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes","volume":"88","author":"Hiroe","year":"2001","journal-title":"Circ Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"e44923","DOI":"10.1371\/journal.pone.0044923","article-title":"Phosphorylation of Rad9 at Serine 328 by Cyclin A-Cdk2 Triggers Apoptosis via Interfering Bcl-xL","volume":"7","author":"Jin","year":"2012","journal-title":"PLoS One"},{"key":"46","first-page":"501","article-title":"The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation","volume":"20","author":"Arnold","year":"1999","journal-title":"Endocr Rev"},{"key":"47","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/emboj\/18.6.1571","article-title":"The p21(Cip1) and p27(Kip1) CDK \u201cinhibitors\u201d are essential activators of cyclin D-dependent kinases in murine fibroblasts","volume":"18","author":"Sherr","year":"1999","journal-title":"EMBO J"},{"key":"48","first-page":"8655","article-title":"Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase 6 holoenzyme (cell cycle regulation\/processivity\/protein-protein interaction)","volume":"91","author":"Hurwitz","year":"1994","journal-title":"Biochemistry"},{"key":"49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/MCB.18.1.629","article-title":"Effects of p21(Cip1\/Waf1) at both the G1\/S and the G2\/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication","volume":"18","author":"Reed","year":"1998","journal-title":"Mol Cell Biol"},{"key":"50","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/MCB.17.8.4877","article-title":"WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases","volume":"17","author":"Howard","year":"1997","journal-title":"Mol Cell Biol"},{"key":"51","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1038\/sj.onc.1207571","article-title":"Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle","volume":"23","author":"Gartel","year":"2004","journal-title":"Oncogene"},{"key":"52","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.leu.2404599","article-title":"Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis","volume":"21","author":"Pandiella","year":"2007","journal-title":"Leukemia"},{"key":"53","doi-asserted-by":"crossref","first-page":"e23569","DOI":"10.1371\/journal.pone.0023569","article-title":"Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma","volume":"6","author":"Crispi","year":"2011","journal-title":"PLoS One"},{"key":"54","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1158\/1078-0432.CCR-08-0255","article-title":"Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma","volume":"14","author":"Catalano","year":"2008","journal-title":"Clin Cancer Res"},{"key":"55","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4161\/cbt.12.9.17680","article-title":"Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy","volume":"12","author":"Weiss","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"56","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T12:19:41Z","timestamp":1658924381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.17198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":56,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2017,6,27]]}},"alternative-id":["17198","28476017"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.17198","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,18]]}}}